Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study.
暂无分享,去创建一个
P Aebischer | P Brugières | J. Bloch | P. Remy | J. Lefaucheur | P. Brugières | M. Peschanski | A. Bachoud-Lévi | S. Palfi | N. Déglon | P. Aebischer | J. Nguyen | P. Hantraye | S. Baudic | P. Césaro | M. Boisse | P Remy | P Cesaro | J P Nguyen | P Hantraye | V. Gaura | C Bourdet | L. Winkel | C. Bourdet | M Peschanski | S Palfi | J P Lefaucheur | N Déglon | J Bloch | A C Bachoud-Lévi | L Winkel | V Gaura | M-F Boisse | S Baudic
[1] M. Peschanski,et al. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease. , 2004, Brain : a journal of neurology.
[2] R. Barker,et al. Unilateral transplantation of human primary fetal tissue in four patients with Huntington’s disease: NEST-UK safety report ISRCTN no 36485475 , 2002, Journal of neurology, neurosurgery, and psychiatry.
[3] J. Lefaucheur,et al. Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.
[4] Christopher A Ross,et al. Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.
[5] S. Dunnett,et al. Cell therapy for Huntington's disease, the next step forward , 2002, The Lancet Neurology.
[6] M. Peschanski,et al. Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration , 2002, The Journal of Neuroscience.
[7] M. Peschanski,et al. Fetal neural grafts for Huntington's disease: A prospective view , 2002, Movement disorders : official journal of the Movement Disorder Society.
[8] V. Sossi,et al. Bilateral human fetal striatal transplantation in Huntington’s disease , 2002, Neurology.
[9] Elena Cattaneo,et al. Loss of normal huntingtin function: new developments in Huntington's disease research , 2001, Trends in Neurosciences.
[10] Anne-Catherine Bachoud-Lévi,et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation , 2000, The Lancet.
[11] P Aebischer,et al. Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. , 2000, Human gene therapy.
[12] J. Bloch,et al. Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. , 2000, Human gene therapy.
[13] P. Remy,et al. Safety and Tolerability Assessment of Intrastriatal Neural Allografts in Five Patients with Huntington's Disease , 2000, Experimental Neurology.
[14] L. Raymond,et al. Influence of lamotrigine on progression of early Huntington disease , 1999, Neurology.
[15] J. Kordower,et al. Cellular Delivery of Trophic Factors for the Treatment of Huntington's Disease: Is Neuroprotection Possible? , 1999, Experimental Neurology.
[16] Alfredo Berardelli,et al. Pathophysiology of chorea and bradykinesia in Huntington's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.
[17] Steven Finkbeiner,et al. Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.
[18] M. Peschanski,et al. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.
[19] T. Munsat,et al. Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis , 1996, Neurology.
[20] J. Kordower,et al. Implants of Encapsulated Human CNTF-Producing Fibroblasts Prevent Behavioral Deficits and Striatal Degeneration in a Rodent Model of Huntington’s Disease , 1996, The Journal of Neuroscience.
[21] S. Wiegand,et al. Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] Myriam Schluep,et al. Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients , 1996, Nature Medicine.
[23] N. Déglon,et al. Gene therapy for amyotrophic lateral sclerosis (ALS) using a polymer encapsulated xenogenic cell line engineered to secrete hCNTF. , 1996, Human gene therapy.
[24] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[25] O. Lindvall,et al. Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT‐HD) , 1996, Movement disorders : official journal of the Movement Disorder Society.
[26] G. Parry,et al. A placebo‐controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis , 1996 .
[27] M. Peschanski,et al. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease , 1995, Neuroscience.
[28] A Berardelli,et al. Electromyographic silent period after transcranial brain stimulation in huntington's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[29] H. Thoenen,et al. Actions of CNTF and neurotrophins on degenerating motoneurons: Preclinical studies and clinical implications , 1994, Journal of the Neurological Sciences.
[30] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[31] H. Herzog,et al. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of huntington's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.
[32] K H Sontag,et al. Abnormalities of somatosensory evoked potentials in the quinolinic acid model of Huntington's disease: Evidence that basal ganglia modulate sensory cortical input , 1992, Annals of neurology.